Joshua J. Meeks, MD (he/him/his)

Northwestern University

Joshua Meeks, MD, PhD, is an Associate Professor of Urology, Biochemistry and Molecular Genetics at Northwestern University and the Jesse Brown VAMC. His research laboratory is focused on the molecular pathways involved in the progression of urothelial carcinoma. Dr Meeks specializes in the surgical treatment of non-muscle, muscle-invasive bladder cancer and urothelial carcinoma.

Disclosure information not submitted.

Presentation(s):

• How the Experts Treat NMIBC During A BCG-Shortage Integrating Recent Approvals and Investigational Therapies

  Friday, April 28, 2023
  8:00 AM – 10:00 AM CST

• Bladder Cancer Omics Data: Investigating Mechanisms of Immune Response

  Saturday, April 29, 2023
  9:35 AM – 10:05 AM CST

• Beyond the Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Bladder Cancer

  Sunday, April 30, 2023
  7:30 AM – 10:00 AM CST

• Optimizing BCG Therapy/Managing BCG Toxicity

  Sunday, April 30, 2023
  3:50 PM – 4:10 PM CST